Is statistical significance always significant?

Nutrition in Clinical Practice

Volumn 20, Issue 3, 2005, Pages 303-307

  Koretz, Ronald L ^a  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTERIC FEEDING; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; MEDICAL INFORMATION; MEDICAL RESEARCH; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PREOPERATIVE EVALUATION; QUALITY OF LIFE; REVIEW; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; HUMAN; METHODOLOGY; STANDARD; STATISTICAL ANALYSIS; STATISTICS;

CLINICAL TRIALS; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; HUMANS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 32944461920     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426505020003303     Document Type: Review

References (17)

1. Koretz RL. Death, morbidity, and economics are the only endpoints for trials. Proc Nutr Soc. In press.
2. Muller JM, Brenner U, Dienst C, Pichlmaier H. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet. 1982;1:68-71.
3. Beier-Holgersen R, Boesby S. Influence of postoperative enteral nutrition on postsurgical infections. Gut. 1996;39:833-835.
4. Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 1991;325:525-532.
5. Von Mayenfeldt MF, Meijerink WJHJ, Rouflart NMJ, Buil-Maassen MTHJ, Soeters PB. Perioperative nutritional support: a randomised clinical trial. Clin Nutr. 1992;11:180-186.
6. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA. 1994; 272:122-124.
7. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995;108:1056-1067.
8. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr. 1995;19:356-364.
9. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease. A meta-analysis. Scand J Gastroenterol. 1996; 31:267-272.
10. HIV Surrogate Marker Collaborative Group. Human immunodeficiency virus Type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. AIDS Res Hum Retrovirus. 2000;16:1123-1133.
11. Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology. 2001;121:970-1001.
12. Koretz RL, Braunschweig CL. Enteral versus parenteral nutrition: a systematic review of the randomized trials [abstract]. JPEN J Parenter Enteral Nutr. 2004;28:S15-S16.
13. Koretz RL, Lipman TO. Enteral nutrition: a systematic review of the randomized trials [abstract]. JPEN J Parenter Enteral Nutr. 2004;28:S16.
14. Weaver M, Krieger J, Castorina J, Walls M, Ciske S. Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines. Arch Intern Med. 2001;161:111-120.
15. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults. A cost-effectiveness analysis. JAMA. 2003;290:3101-3114.
16. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5:559-575.
17. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med. 1995;23:436-449.